Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation

Pharmacological Research

Volumn 61, Issue 5, 2010, Pages 410-418

  Anwar mohamed, Anwar ^a   Zordoky, Beshay N M ^a   Aboutabl, Mona E ^a   El Kadi, Ayman O S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cytochrome P450; Dihydroxyeicosatrienoic acid; Epoxyeicosatrienoic acid; Hydroxyeicosatetraenoic acid; Inflammation; Lipopolysaccharide

Indexed keywords

ALKANE 1 MONOOXYGENASE; ARACHIDONIC ACID; CYTOCHROME P450; EPOXYGENASE; EPOXYICOSATRIENOIC ACID; HYDROXYICOSATETRAENOIC ACID; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARACHIDONIC ACID METABOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; ENZYME ANALYSIS; ENZYME INDUCTION; HEART; HEART PROTECTION; INFLAMMATION; KIDNEY PARENCHYMA; LIQUID CHROMATOGRAPHY; LIVER PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALKANE 1-MONOOXYGENASE; ANIMALS; ARACHIDONIC ACID; BLOTTING, WESTERN; CYTOCHROME P-450 ENZYME SYSTEM; DNA, COMPLEMENTARY; HEART; HYDROXYEICOSATETRAENOIC ACIDS; INFLAMMATION; KIDNEY; LIPOPOLYSACCHARIDES; LIVER; MALE; MICROSOMES; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 77950628202     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.12.015     Document Type: Article

References (56)

1. Ridker P.M. Fibrinolytic and inflammatory markers for arterial occlusion: the evolving epidemiology of thrombosis and hemostasis. Thromb Haemost 1997, 78:53-59.
2. Blum A., Miller H. Role of cytokines in heart failure. Am Heart J 1998, 135:181-186.
3. Blum A., Miller H. Pathophysiological role of cytokines in congestive heart failure. Annu Rev Med 2001, 52:15-27.
4. Mann D.L. Recent insights into the role of tumor necrosis factor in the failing heart. Heart Fail Rev 2001, 6:71-80.
5. Rattazzi M., Puato M., Faggin E., Bertipaglia B., Zambon A., Pauletto P. C-reactive protein and interleukin-6 in vascular disease: culprits or passive bystanders?. J Hypertens 2003, 21:1787-1803.
6. Morgan E.T. Regulation of cytochrome p450 by inflammatory mediators: why and how?. Drug Metab Dispos 2001, 29:207-212.
7. Gauthier K.M., Yang W., Gross G.J., Campbell W.B. Roles of epoxyeicosatrienoic acids in vascular regulation and cardiac preconditioning. J Cardiovasc Pharmacol 2007, 50:601-608.
8. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002, 82:131-185.
9. Spector A.A., Norris A.W. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 2007, 292:C996-1012.
10. Kroetz D.L., Zeldin D.C. Cytochrome P450 pathways of arachidonic acid metabolism. Curr Opin Lipidol 2002, 13:273-283.
11. Zordoky B.N., Aboutabl M.E., El-Kadi A.O. Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats. Drug Metab Dispos 2008, 36:2277-2286.
12. Levick S.P., Loch D.C., Taylor S.M., Janicki J.S. Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation. J Immunol 2007, 178:641-646.
13. Elbekai R.H., El-Kadi A.O. Cytochrome P450 enzymes: central players in cardiovascular health and disease. Pharmacol Ther 2006, 112:564-587.
14. Miyata N., Roman R.J. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. J Smooth Muscle Res 2005, 41:175-193.
15. Chabova V.C., Kramer H.J., Vaneckova I., Vernerova Z., Eis V., Tesar V., et al. Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats. Vascul Pharmacol 2007, 47:145-159.
16. Lv X., Wan J., Yang J., Cheng H., Li Y., Ao Y., et al. Cytochrome P450 omega-hydroxylase inhibition reduces cardiomyocyte apoptosis via activation of ERK1/2 signaling in rat myocardial ischemia-reperfusion. Eur J Pharmacol 2008, 596:118-126.
17. Volpe A., Biasi D., Caramaschi P., Mantovani W., Bambara L.M., Canestrini S., et al. Levels of F2-isoprostanes in systemic sclerosis: correlation with clinical features. Rheumatology (Oxford) 2006, 45:314-320.
18. Yousif M.H., Benter I.F., Roman R.J. Cytochrome P450 metabolites of arachidonic acid play a role in the enhanced cardiac dysfunction in diabetic rats following ischaemic reperfusion injury. Auton Autacoid Pharmacol 2009, 29:33-41.
19. Mathison J.C., Ulevitch R.J. The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits. J Immunol 1979, 123:2133-2143.
20. Tunctan B., Korkmaz B., Buharalioglu C.K., Firat S.S., Anjaiah S., Falck J., et al. A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats. Shock 2008, 30:329-335.
21. Baldwin S.J., Bramhall J.L., Ashby C.A., Yue L., Murdock P.R., Hood S.R., et al. Cytochrome P450 gene induction in rats ex vivo assessed by quantitative real-time reverse transcriptase-polymerase chain reaction (TaqMan). Drug Metab Dispos 2006, 34:1063-1069.
22. Rollin R., Mediero A., Fernandez-Cruz A., Fernandez-Durango R. Downregulation of the atrial natriuretic peptide/natriuretic peptide receptor-C system in the early stages of diabetic retinopathy in the rat. Mol Vis 2005, 11:216-224.
23. Wang S., Hartley D.P., Ciccotto S.L., Vincent S.H., Franklin R.B., Kim M.S. Induction of hepatic phase II drug-metabolizing enzymes by 1,7-phenanthroline in rats is accompanied by induction of MRP3. Drug Metab Dispos 2003, 31:773-775.
24. Hirasawa F., Kawagoe M., Arany S., Koizumi Y., Ueno Y., Sugiyama T. Styrene monomer primarily induces CYP2B1 mRNA in rat liver. Xenobiotica 2005, 35:1089-1099.
25. Bleicher K.B., Pippert T.R., Glaab W.E., Skopek T.R., Sina J.F., Umbenhauer D.R. Use of real-time gene-specific polymerase chain reaction to measure RNA expression of three family members of rat cytochrome P450 4A. J Biochem Mol Toxicol 2001, 15:133-142.
26. Kalsotra A., Anakk S., Boehme C.L., Strobel H.W. Sexual dimorphism and tissue specificity in the expression of CYP4F forms in Sprague-Dawley rats. Drug Metab Dispos 2002, 30:1022-1028.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
28. Barakat M.M., El-Kadi A.O., du Souich P. L-NAME prevents in vivo the inactivation but not the down-regulation of hepatic cytochrome P450 caused by an acute inflammatory reaction. Life Sci 2001, 69:1559-1571.
29. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
30. Zordoky B.N., Anwar-Mohamed A., Aboutabl M.E., El-Kadi A.O. Acute doxorubicin cardiotoxicity alters cardiac cytochrome P450 expression and arachidonic acid metabolism in rats. Toxicol Appl Pharmacol 2010, 242:38-46.
31. Nithipatikom K., Grall A.J., Holmes B.B., Harder D.R., Falck J.R., Campbell W.B. Liquid chromatographic-electrospray ionization-mass spectrometric analysis of cytochrome P450 metabolites of arachidonic acid. Anal Biochem 2001, 298:327-336.
32. Mitchell S.R., Sewer M.B., Kardar S.S., Morgan E.T. Characterization of CYP4A induction in rat liver by inflammatory stimuli: dependence on sex, strain, and inflammation-evoked hypophagia. Drug Metab Dispos 2001, 29:17-22.
33. Fife K.L., Liu Y., Schmelzer K.R., Tsai H.J., Kim I.H., Morisseau C., et al. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation. J Pharmacol Exp Ther 2008, 327:707-715.
34. Node K., Ruan X.L., Dai J., Yang S.X., Graham L., Zeldin D.C., et al. Activation of Galpha s mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids. J Biol Chem 2001, 276:15983-15989.
35. Lamarque D., Kiss J., Tankovic J., Flejou J.F., Delchier J.C., Whittle B.J. Induction of nitric oxide synthase in vivo and cell injury in rat duodenal epithelium by a water soluble extract of Helicobacter pylori. Br J Pharmacol 1998, 123:1073-1078.
36. Morgan E.T., Li-Masters T., Cheng P.Y. Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology 2002, 181-182:207-210.
37. Simpson A.E., Tomkins P.T., Cooper K.L. An investigation of the temporal induction of cytokine mRNAs in LPS-challenged thioglycollate-elicited murine peritoneal macrophages using the reverse transcription polymerase chain reaction. Inflamm Res 1997, 46:65-71.
38. Liu D.F., Wei W., Song L.H. Upregulation of TNF-alpha and IL-6 mRNA in mouse liver induced by bacille Calmette-Guerin plus lipopolysaccharide. Acta Pharmacol Sin 2006, 27:460-468.
39. de Vos A.F., van Haren M.A., Verhagen C., Hoekzema R., Kijlstra A. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994, 35:1100-1106.
40. Grinevich V., Knepper M.A., Verbalis J., Reyes I., Aguilera G. Acute endotoxemia in rats induces down-regulation of V2 vasopressin receptors and aquaporin-2 content in the kidney medulla. Kidney Int 2004, 65:54-62.
41. Tian Y. Ah receptor and NF-kappaB interplay on the stage of epigenome. Biochem Pharmacol 2009, 77:670-680.
42. Ke S., Rabson A.B., Germino J.F., Gallo M.A., Tian Y. Mechanism of suppression of cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J Biol Chem 2001, 276:39638-39644.
43. Zordoky B.N., El-Kadi A.O. Role of NF-kappaB in the regulation of cytochrome P450 enzymes. Curr Drug Metab 2009, 10:164-178.
44. Malaplate-Armand C., Ferrari L., Masson C., Siest G., Batt A.M. Astroglial CYP1B1 up-regulation in inflammatory/oxidative toxic conditions: IL-1beta effect and protection by N-acetylcysteine. Toxicol Lett 2003, 138:243-251.
45. Bhattacharyya K.K., Brake P.B., Eltom S.E., Otto S.A., Jefcoate C.R. Identification of a rat adrenal cytochrome P450 active in polycyclic hydrocarbon metabolism as rat CYP1B1. Demonstration of a unique tissue-specific pattern of hormonal and aryl hydrocarbon receptor-linked regulation. J Biol Chem 1995, 270:11595-11602.
46. Umannova L., Zatloukalova J., Machala M., Krcmar P., Majkova Z., Hennig B., et al. Tumor necrosis factor-alpha modulates effects of aryl hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver " stem-like" cells. Toxicol Sci 2007, 99:79-89.
47. Li-Masters T., Morgan E.T. Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: independence from nitric oxide production by inducible nitric oxide synthase. Biochem Pharmacol 2002, 64:1703-1711.
48. Renton K.W. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab 2004, 5:235-243.
49. Morgan E.T., Norman C.A. Pretranslational suppression of cytochrome P-450h (IIC11) gene expression in rat liver after administration of interferon inducers. Drug Metab Dispos 1990, 18:649-653.
50. Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J.B. Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 2004, 32:840-847.
51. Ng V.Y., Huang Y., Reddy L.M., Falck J.R., Lin E.T., Kroetz D.L. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha. Drug Metab Dispos 2007, 35:1126-1134.
52. Laethem R.M., Halpert J.R., Koop D.R. Epoxidation of arachidonic acid as an active-site probe of cytochrome P-450 2B isoforms. Biochim Biophys Acta 1994, 1206:42-48.
53. Laethem R.M., Balazy M., Falck J.R., Laethem C.L., Koop D.R. Formation of 19(S)-, 19(R)-, and 18(R)-hydroxyeicosatetraenoic acids by alcohol-inducible cytochrome P450 2E1. J Biol Chem 1993, 268:12912-12918.
54. Kalsotra A., Cui X., Antonovic L., Robida A.M., Morgan E.T., Strobel H.W. Inflammatory prompts produce isoform-specific changes in the expression of leukotriene B(4) omega-hydroxylases in rat liver and kidney. FEBS Lett 2003, 555:236-242.
55. Kalsotra A., Strobel H.W. Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism. Pharmacol Ther 2006, 112:589-611.
56. Benter I.F., Francis I., Cojocel C., Juggi J.S., Yousif M.H., Canatan H. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Auton Autacoid Pharmacol 2005, 25:143-154.